This increase is thought to be because of the proinflammatory environment in NASH, as evidenced by the upregulation of LCN2 in the HepG2 hepatoma cell line upon exposure to proinflammatory mediators, such as TNF-α and IL-6 (136). This evidence concerns the gene LCN2 and metabolic dysfunction-associated steatohepatitis.